Endometrial thickening, or endometrial hyperplasia, always requires close monitoring or treatment. The specific treatment approach depends on the presence or absence of atypical cells. While the risk of endometrial hyperplasia without atypia progressing to endometrial cancer is generally considered low, studies indicate that approximately 5% of women with this condition may still develop endometrial cancer. Therefore, diligent follow-up is essential.